The global Interventional Radiology Market is anticipated to increase from US$ 24.9 Billion in 2021 to US$ 42.7 Billion market by 2032, growing at a CAGR of 5% during the forecast period, according to the exclusive analysis of Future Market Insights (FMI).
There is an increasing need for cutting-edge treatment methods using scanners and X-ray vision technology due to the rising prevalence of numerous chronic diseases worldwide. In recent years, the market for these kinds of interventional radiology glasses and equipment has expanded since they not only aid in the efficient treatment of diseases but also enable a better opportunity for early diagnosis.
Embrace the power of visuals – claim your complimentary report. @
https://www.futuremarketinsights.com/reports/sample/rep-gb-14344
The necessary impetus for the rapid growth of interventional radiology, which is visible in emerging nations as well, has been provided by the introduction of interventional radiology in all levels of healthcare facilities. As the non-emergency medical services were abruptly halted during the outbreak of Covid-19 Mandeville in 2020 it had some negative impacts on the growing demand for interventional radiology devices installations.
However, the later discovery of seriousness associated with co-morbid diseases the global interventional radiology market surged with rising introduction of interventional radiology in new healthcare and medical facilities. In the post-pandemic years the application of radiology equipment has grown favouring the interventional radiology service providers. Several devices equipped with modern technologies such as X-ray systems, MRI Scanners, CT Scanners and other type of medical imaging equipment have dominated the health care sector in recent days.
Key Takeaways
- By 20221, Cardiology Segment was valued at US$ 7.7 Bn in terms of revenue contributed the global interventional radiology market.
- The Gastroenterology segment is poised to record a higher growth projection during the forecast years reaching a value of more than US $ 2 Bn by 2028.
- Among several procedures angioplasty segment will expected to grow at a CAGR of 5.8% during the forecast period.
- US market dominates the interventional radiology for medical students having a net worth of more than US$ 8 Bn.
- In Europe, Germany is the prominent region for the interventional radiology market players valued at US$ 1.5 Bn in terms of revenue generated.
Competitive Landscape
Carestream Health Inc., Hologic Inc., GE Healthcare, Fujifilm Corporation, Samsung Healthcare (Samsung Electronics Co., Ltd.), Shimadzu Corporation, Siemens Healthineers, Canon Medical Systems Corporation, and Olympus Corporation are some of the prominent players of the global interventional radiology market covered by the market analysis report.
A large number of local players have occupied the market by supplying equipments related to interventional radiology for medical student’s requirements.
- In the field of ultrasound, digital radiography and computed tomography Samsung Healthcare, a subsidiary of Samsung Electronics Co., Ltd, launched a premium product for diagnostic imaging solutions in December 2020. This initiative for ultrasound guided interventional procedures carried out at Radiology Society of North America (RSNA) 2020 assisted the company in expanding their product portfolio in North America and beyond.
- Canon Medical launched an upgraded product under the Aquilion ONE/PRISM Edition by the name of One-Beat Spectral Cardiac CT in November 2020. THE Aquillion Edition assisted with deep learning spectral capabilities is a major development in the field of cardiac exam and after interventional radiology glasses.
- GE Healthcare division of General Electrical Company launched an advanced ultrasound system by the name of LOGIQ E10 in March 2018. This system has been equipped with comprehensive tools that can provide treatment for a wife range of diseases and remote control applications to improve efficiency.
Empower your knowledge base through our impactful methodology. @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14344
Key Segments
By Product:
- MRI Systems
- CT Scanners
- Ultrasound Imaging Systems
- Angiography Systems
- Others
By Procedure:
- Angioplasty
- Biopsy
- Embolization
- Peripheral Embolization
- Prostatic Artery Embolization
- Genicular Artery Embolization
- Fibroid
- Others
- Thrombolysis
- Vertebroplasty
- Nephrostomy
- Interventional Oncology
- MSK Intervention
- Others
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
By Application:
- Cardiology
- Oncology
- Urology
- Gastroenterology
- Obstetrics
- Gynaecology
- Others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
